- Press Releases
- Explore Topics
- People and Events
Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
Sometimes anticancer antibodies press on the gas and the brakes at the same time. New research might help them accelerate better
Natural antibodies found in tumors could point the way toward improved immunotherapy
Off-the-shelf therapies to be developed for entire groups of patients
The findings of a new study may explain the microbiome-immunotherapy connection
A study of melanoma cells explains a puzzling response they exhibit to ward off T cell attacks
A possible cause for cancer resistance to immunotherapy could be reversed
Overexpression of certain immunoproteasome subunits in melanoma are tied to anti-cancer immune activity
"We attain higher achievement, better results and the opportunity to advance our scientific careers"
Weizmann Institute of Science research shows heterogeneity in melanoma tumors prevents effective immune responses...
An advanced method for investigating the activity of single cells could lead to better immunotherapy drugs